Long Non-Coding RNAs in Cardiac and Pulmonary Fibroblasts and Fibrosis

Research output: Contribution to journalComment/debateResearchpeer-review

1 Citation (Scopus)
6 Downloads (Pure)


The cardiopulmonary system delivers oxygen throughout the body via blood circulation. It is an essential part of the body to sustain the lives of organisms. The integral parts of the cardiopulmonary system—the heart and lungs—are constantly exposed to damaging agents (e.g., dust, viruses), and can be greatly affected by injuries caused by dysfunction in tissues (e.g., myocardial infarction). When damaged, mesenchymal cells, such as fibroblasts, are activated to become myofibroblasts to initiate fibrosis as part of a regenerative mechanism. In diseased states, the excess accumulation of extracellular matrices secreted by myofibroblasts results in further dysfunction in the damaged organs. These fibrotic tissues cannot easily be removed. Thus, there is a growing interest in understanding the fibrotic process, as well as finding biomolecules that can be targets for slowing down or potentially stopping fibrosis. Among these biomolecules, the interest in studying long non-coding RNAs (lncRNAs; any non-protein-coding RNAs longer than 200 nucleotides) has intensified in recent years. In this commentary, we summarize the current status of lncRNA research in the cardiopulmonary system by focusing on cardiac and pulmonary fibrosis.
Original languageEnglish
Article number53
JournalNon-coding RNA
Issue number4
Number of pages12
Publication statusPublished - 15 Jul 2022


  • cardiac
  • fibroblast
  • fibrosis
  • heart
  • lncRNA
  • lung


Dive into the research topics of 'Long Non-Coding RNAs in Cardiac and Pulmonary Fibroblasts and Fibrosis'. Together they form a unique fingerprint.

Cite this